Target intelligence / Profile preview

RRN3 Pseudogene 3 (RRN3P3)

Target
RRN3P3
Molecular classification
Other; classified as a pseudogene
01

Overview

RRN3 Pseudogene 3 (RRN3P3) is a non-protein-coding pseudogene, representing a genomic copy related to the RRN3 gene, which encodes a transcription initiation factor for RNA polymerase I. Unlike its functional parent gene (RRN3), RRN3P3 is not known to produce a protein or have a documented biological activity. Pseudogenes occasionally participate in the regulation of gene expression through non-coding RNAs but there is currently no evidence of such a function for RRN3P3. It is not considered a therapeutic target in pharmacology or molecular medicine, and there are no associated drugs or safety concerns identified for this pseudogene.

Other names
RRN3 Homolog, RNA Polymerase I Transcription Factor Pseudogene 3RNA Polymerase I Transcription Factor Homolog (S. cerevisiae) Pseudogene 3RRN3 RNA Polymerase I Transcription Factor Homolog PseudogeneRNA Polymerase I Transcription Factor Homolog Pseudogene 3
02

Mechanism of action

None applicable; pseudogenes are not direct drug targets

03

Biological functions

Other; pseudogenes sometimes produce non-coding RNAs or have regulatory effects, but no specific function is documented for RRN3P3
04

Disease associations

Other; while some pseudogenes can be implicated through non-coding RNAs in cancer or other diseases, RRN3P3’s direct disease role is undocumented

Beyond the preview

Go deeper on RRN3 Pseudogene 3 (RRN3P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RRN3 Pseudogene 3 (RRN3P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call